Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers

被引:0
|
作者
Sanchez-Cespedes, M
Ahrendt, SA
Piantadosi, S
Rosell, R
Monzo, M
Wu, L
Westra, WH
Yang, SC
Jen, J
Sidransky, D
机构
[1] Johns Hopkins Univ, Sch Med, Div Head & Neck Canc Res, Dept Otolaryngol, Baltimore, MD 21206 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol Biostat, Baltimore, MD 21206 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21206 USA
[4] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21206 USA
[5] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA
[6] Hosp Germans Trias & Pujol, Dept Med Oncol, Barcelona 08916, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The etiology of lung tumors arising in nonsmokers remains unclear, Although mutations in the K-ras and p53 genes have been reported to be significantly higher in smoking-related lung carcinomas, in the present study we performed a more comprehensive analysis in search of additional genetic changes between lung adenocarcinoma from tobacco- and non-tobacco-exposed patients. We selected a matched cohort of 18 lifetime nonsmoking and 27 smoking patients diagnosed with primary adenocarcinoma of the lung and searched for chromosomal alterations in each tumor by testing normal and tumor tissue with 54 highly polymorphic microsatellite markers located on 28 different chromosomal arms. Allelic losses or gains at chromosomal arms 3p (37 versus 6%), 6q (46 versus 12%), 9p (65 versus 22%), 16p (28 versus 0%), 17p (45 versus 11%), and 19p (58 versus 16%) were present significantly more often in adenocarcinomas from smokers than from nonsmokers. Chromosomal arms showing allelic imbalance in lung tumors from nonsmokers were rare but occurred more often at 19q (22%), 12p (22%), and 9p (22%). The FAL (fractional allelic loss or gain) is defined as the percentage of chromosomal arm losses/gains among the total informative chromosomal arms. Tumors from smokers harbored higher levels of FAL (13 (48%) of 27 showed FAL greater than or equal to 0.3) compared with the lung tumors from the nonsmoker patients (2 (11%) of 18 showed FAL greater than or equal to 0.3; P = 0.02; odds ratio, 0.13; 95% confidence interval, 0.01-0.79). Our data demonstrate that widespread chromosomal abnormalities are frequent in lung adenocarcinoma from smokers, whereas these abnormalities are infrequent in such tumors arising in nonsmokers. These observations support the notion that lung cancers in nonsmokers arise through genetic alterations distinct from the common events observed in tumors from smokers.
引用
收藏
页码:1309 / 1313
页数:5
相关论文
共 50 条
  • [1] Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patients
    Slebos, RJC
    Livanos, E
    Yim, HW
    Randell, SH
    Parsons, AM
    Detterbeck, FC
    Rivera, MP
    Taylor, JA
    [J]. CANCER GENETICS AND CYTOGENETICS, 2005, 159 (02) : 137 - 142
  • [2] Germline mutations and onset of lung adenocarcinoma in smokers and nonsmokers.
    Reckamp, Karen L.
    Slavin, Thomas Paul
    Gray, Stacy W.
    Behrendt, Carolyn E.
    Castillo, Danielle
    Koczywas, Marianna
    Cristea, Mihaela C.
    Babski, Kirsten
    Stearns, Donna
    Marcum, Catherine A.
    Rodriguez, Yeny
    Hass, Amie
    Vecchio, Mary
    Alferez, Anali Pamela Mora
    Cervantes, Aleck
    Sand, Sharon
    Mach, Stephanie L.
    Tsou, Terrence
    Salgia, Ravi
    Weitzel, Jeffrey N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] The nonsmokers' and smokers' pathways in lung adenocarcinoma: Histological progression and molecular bases
    Okudela, Koji
    Matsumura, Mai
    Arai, Hiromasa
    Woo, Tetsukan
    [J]. CANCER SCIENCE, 2021, 112 (09) : 3411 - 3418
  • [4] LUNG VOLUME IN SMOKERS AND NONSMOKERS
    BLACKBURN, H
    BROZEK, J
    TAYLOR, HL
    [J]. ANNALS OF INTERNAL MEDICINE, 1959, 51 (01) : 68 - 77
  • [5] Seqing The Shared And Distinct Transcriptional Events Underlying Lung Adenocarcinoma In Smokers And Nonsmokers
    Kusko, R. L.
    Perez-Rogers, J.
    Wang, T. W.
    Garrison, C.
    Luo, L.
    Tellez, C.
    Liu, G.
    Steiling, K.
    Belinsky, S. A.
    Beane, J.
    Lenburg, M.
    Spira, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [6] Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma
    Ripley, R. Taylor
    McMillan, Robert R.
    Sima, Camelia S.
    Hasan, Saad M.
    Ahmad, Usman
    Lou, Feiran
    Jones, David R.
    Rusch, Valerie W.
    Rizk, Nabil P.
    Huang, James
    [J]. ANNALS OF THORACIC SURGERY, 2014, 98 (03): : 968 - 974
  • [7] REGIONAL LUNG EPITHELIAL LEAKINESS IN SMOKERS AND NONSMOKERS
    ODOHERTY, MJ
    PAGE, CJ
    CROFT, DN
    BATEMAN, NT
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1985, 6 (06) : 353 - 357
  • [9] Gene expression in lung adenocarcinomas of smokers and nonsmokers
    Powell, CA
    Spira, A
    Derti, A
    DeLisi, C
    Liu, G
    Borczuk, A
    Busch, S
    Sahasrabudhe, S
    Chen, YD
    Sugarbaker, D
    Bueno, R
    Richards, WG
    Brody, JS
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 29 (02) : 157 - 162
  • [10] Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
    William N Rom
    Judith D Goldberg
    Doreen Addrizzo-Harris
    Heather N Watson
    Michael Khilkin
    Alissa K Greenberg
    David P Naidich
    Bernard Crawford
    Ellen Eylers
    Daorong Liu
    Eng M Tan
    [J]. BMC Cancer, 10